A unique range of over 3000 novel substituted fluoro aromatic compounds functionalised with a variety of synthetically useful reactive groups.
Entrants so far have come from Shire, Bayer, AbbVie, Eisai Europe, Novartis, GSK, MSD, Lundbeck, HFA Healthcare Products, Sandoz and...
Read More >
Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >